Tocotrienol Against the Progression of End Stage Liver Disease
Condition(s):End Stage Liver Disease; NASH – Nonalcoholic Steatohepatitis; NAFLD – Nonalcoholic Fatty Liver DiseaseLast Updated:July 20, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):End Stage Liver Disease; NASH – Nonalcoholic Steatohepatitis; NAFLD – Nonalcoholic Fatty Liver DiseaseLast Updated:July 20, 2023Recruiting
Condition(s):Non-Alcoholic Fatty Liver Disease; Non-alcoholic Steatohepatitis; NAFLD; NASH; NASH – Nonalcoholic Steatohepatitis; Childhood Obesity; Childhood Overweight; Pediatric ObesityLast Updated:March 5, 2021Unknown status
Condition(s):Non Alcoholic Steatohepatitis (NASH)Last Updated:September 8, 2022Recruiting
Condition(s):Hypogonadism, Male; Diabetes Mellitus, Type 2; ObesityLast Updated:January 4, 2019Completed
Condition(s):Type 2 Diabetes; Non-alcoholic Steatohepatitis (NASH); Non-alcoholic Fatty Liver Disease (NAFLD)Last Updated:January 24, 2024Recruiting
Condition(s):HIV Mono InfectionLast Updated:June 17, 2019Completed
Condition(s):Psoriasis Chronic; Liver Fibrosis; Fatty Liver; Non-alcoholic Fatty Liver DiseaseLast Updated:August 4, 2017Unknown status
Condition(s):NAFLD; NASH; NASH – Nonalcoholic Steatohepatitis; Fibrosis, Liver; Steatosis of Liver; Hepatocellular Carcinoma; Cardiovascular Diseases; Type 2 Diabetes; Dyslipidaemia; Hypertension; Obesity; Other Associated ComorbiditiesLast Updated:January 6, 2023Recruiting
Condition(s):Obesity; NAFLDLast Updated:January 2, 2024Recruiting
Condition(s):Nonalcoholic Fatty Liver; Nonalcoholic Steatohepatitis; Fatty LiverLast Updated:July 12, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.